Director, Regulatory Affairs – Strategy

🕒 vor 1 Monat

☕ Washington – Remote

☕ Washington – Remote

💵 $220.000 - $260.000 / Jahr

⏰ Vollzeit

🔴 Experte

🚔 Compliance

👻 Geisterscore 9%

Was es bedeutet: wie wahrscheinlich diese Stelle offen bleibt, ohne dass aktiv eingestellt wird.So liest du es: 60 % oder höher heißt, wir halten das für einen Geisterjob. Niedrigere Werte sind weniger bedenklich.Wie wir werten: Dauer offen, Neuveröffentlichungen, offene Stellen vs Teamgröße, wie schnell Stellen geschlossen werden, und ob ein Gehalt angegeben ist.Hinweis: eine Schätzung aus öffentlichen Daten, kein Urteil über das Unternehmen. Echte Stellen können hoch punkten, nutze es also als Hinweis, nicht als Fakt.

Jetzt Bewerben

Ähnliche Remote-Jobs finden

E-Mail-Benachrichtigung für neue Jobs einrichten

📊 Überprüfen Sie Ihre Lebenslauf-Bewertung für diese Stelle

Verbessern Sie Ihre Chancen auf ein Vorstellungsgespräch, indem Sie Ihre Lebenslauf-Bewertung vor der Bewerbung überprüfen.

Lebenslauf hochladen

LeonaBio

WebsiteLinkedInAlle Stellen

51 - 200 Mitarbeiter

🧬 Biotechnologie

💊 Pharmazie

🏥 Gesundheitswesen

💰 €103.500.000 Post IPO equity im 2021-02

Biotechnology • Pharmaceuticals • Healthcare

LeonaBio ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung neuartiger niedermolekularer Therapien für schwerwiegende Krankheiten mit begrenzten Behandlungsmöglichkeiten konzentriert. Zu den führenden Kandidaten gehören Lasofoxifen und Brelgometon (ATH-1105), und das Unternehmen führt klinische Studien durch, um Sicherheit und Wirksamkeit zu bewerten, als Teil seiner Mission, die Patientenversorgung zu verbessern. LeonaBio ist in den Bereichen Medizin und Patientenarbeit tätig und hat kürzlich ATH-1105 auf einem ALS-Arzneimittelentwicklungsgipfel präsentiert, was auf eine Beteiligung an der Forschung zu neurodegenerativen Erkrankungen hinweist.

Beschreibung

• Own global regulatory strategy for both development programs, including target product profile, labeling, filing sequence, and expedited-pathway strategy • Translate regulatory strategy into dated plans aligned with clinical, CMC, and program timelines • Own the regulatory critical path and escalate risks with recommended options • Lead US marketing application readiness through submission-level authoring, sign-off, and end-to-end review-period management • Plan post-approval lifecycle management, including commitments, supplements, and labeling changes • Own health authority strategy and execution across FDA and EMA interactions, including briefing packages, question strategy, and rehearsal • Anticipate regulatory risks, questions, and objections and develop proactive, evidence-based, and contingency strategies • Lead regulatory work to move the early-phase program into late-phase development and reach agreement on a registration-enabling design • Serve as the primary company contact with FDA and manage ex-US interactions through regional consultants and partners • Manage consultants and vendors on scope, quality, and timeline • Integrate regulatory considerations into clinical development, translational science, biostatistics, pharmacovigilance, regulatory operations, medical affairs, and CMC planning • Represent Regulatory Affairs on program teams and governance forums and review regulatory content • Translate regulatory requirements, intelligence, and health authority feedback into actionable recommendations • Build submission standards, health authority processes, and regulatory intelligence infrastructure • Maintain compliance with ICH guidance and internal SOPs • Operate within a lean, cross-functional team with no direct reports at hire

🎯 Anforderungen

• Advanced degree in a life science discipline (PharmD, PhD, MD, MS) preferred • 8+ years of experience in biopharmaceutical regulatory affairs, including 5+ years in global regulatory strategy • Candidates with a higher level of education may be considered with fewer years of experience • Demonstrated ownership of at least one US marketing application (NDA or BLA) or major US/EU submission, from readiness through submission and ideally approval • Direct experience leading FDA meetings as the regulatory lead, including briefing authorship and a speaking role • Experience carrying a program from early into late-phase development, including reaching agreement with a health authority on a registration-enabling design • Working knowledge of ex-US requirements (EU CTR/CTIS, MAA, Scientific Advice) and familiarity with at least one other major region • Excellent scientific writing and speaking skills, and sound judgment under incomplete information • Ability to leverage AI-enabled tools and emerging technologies for regulatory strategy, intelligence, authoring, data analysis, and operational efficiency while ensuring scientific rigor and compliance • Ability to develop, defend, and adapt regulatory strategy where precedent is limited, evolving, or subject to interpretation • Ability to influence cross-functional teams, build stakeholder alignment, and drive decisions without direct authority • Experience balancing regulatory, scientific, operational, and benefit-risk considerations • Experience in oncology and/or neurology, neurodegenerative, or rare disease development preferred • Expedited program experience preferred: Fast Track, Breakthrough Therapy, orphan drug designation, accelerated approval, or PRIME • Companion diagnostic or drug-device co-development experience preferred • Sufficient regulatory CMC literacy to partner with a dedicated CMC regulatory counterpart • Experience in a lean biotechnology environment where strategic leadership, independent decision-making, and hands-on execution are important

🏖️ Vorteile

• Approximately 10–15% travel • Flexibility for West Coast time zone • Significant autonomy and direct exposure to executive leadership • Opportunity to shape regulatory strategy across the organization • Potential to grow a small team over time